Table 1 Patient, tumor and treatment-related characteristics
Characteristics | Value |
|---|---|
Age, years, median (range) | 69 (49–92) |
Gender | Â |
Male | 55 (78.6%) |
Female | 15 (21.4) |
History of prior TUR-BT | Â |
Initial treatment | 50 (71.4%) |
Recurrence after previous TURBT | 20 (28.6%) |
ECOG Performance status | Â |
0 | 26 (37.1%) |
1 | 43 (61.5%) |
2 | 1 (1.4%) |
Comorbidities | Â |
No | 20 (28.6%) |
Yes | 50 (71.4%) |
Pathology | Â |
Transitional cell carcinoma | 65 (92.9%) |
Adenocarcinoma | 1 (1.4%) |
Other histology or missing record | 4 (5.7%) |
Grade | Â |
High | 55 (78.6%) |
Low | 1 (1.4%) |
Missing record | 14 (20.0%) |
Clinical T stage | Â |
T2 | 41 (58.6%) |
T3 | 16 (22.9%) |
T4 | 13 (18.6%) |
Focality | Â |
Multifocal | 26 (37.2%) |
Single | 44 (62.8%) |
Hydronephrosis | Â |
No | 39 (55.7%) |
Yes | 31 (44.3%) |
Procedure before radiotherapy (RT) | Â |
Transurethral resection (TUR) | 64 (91.4%) |
Partial cystectomy | 4 (5.7%) |
Cystoscopic biopsy only | 2 (2.9%) |